Robert W Baird
View Older Stories View More Recent Stories
-
Baird Starts Fidus Investment Corp (FDUS) at Outperform
-
Baird Upgrades Campus Crest Communities (CCG) to Outperform
-
Baird Reiterates an 'Outperform' on Human Genome Sciences (HGSI); 2 Survey on Benlysta Launch: Signs of Armageddon Nowhere To Be Found
-
Chuy’s Holdings Files $75M IPO
-
Baird Downgrades Nalco Holding Co. (NLC) to Neutral
-
Baird Upgrades U-Store-It (YSI) to Outperform
-
Baird Upgrades Grand Canyon Education (LOPE) to Outperform
-
Unusual 11 Mid-Day Movers 08/04: (WWWW) (ATSG) (EM) Higher; (DNDN) (AIB) (NCIT) Lower
-
Notable 52-Week Highs and Lows of the Day 08/04: (KFT) (AUY) (CBOU) High; (DNDN) (PMI) (ENTR) Low
-
Morning Movers 08/04: (WWWW) (SRDX) (ATSG) (LHCG) Higher; (DNDN) (ENTR) (NCIT) (GTIV) (CLWR) Lower
-
Notable Analyst Rating Changes 08/04: (EMC) (MCD) (TIF) Upgraded; (DNDN) (WFR) (WLT) Downgraded
-
Baird Upgrades Merge Healthcare (MRGE) to Outperform
-
Baird Downgrades Dendreon (DNDN) to Neutral; Too Many Unanswered Questions
-
Exa Corp. (EXA) Files $86.25M IPO
-
Baird Says Dendreon (DNDN) Results and Guidance "Bad" and "Worse"
-
Baird Downgrades R.R. Donnelley (RRD) to Neutral
-
Baird Upgrades Fiserv (FISV) to Outperform
-
Vocera Communications (VCRA) Files $80M IPO
-
Baird Maintains Acorda Therapeutics (ACOR) Neutral Rating, Says Takeout Still Seems Best Option
-
Ignite Restaurant Group Files $100M IPO
-
Notable Analyst Rating Changes 08/01: (RSH) (ACI) (SPF) Upgraded; (SUNH) (KND) (BCSI) Downgraded
-
8 Firms Start Coverage on Vanguard Health (VHS), All at Buy
-
Baird Upgrades Rockwell Automation (ROK) to Outperform
-
Notable Analyst Rating Changes 07/29: (MO) (WLL) (EVEP) Upgraded; (CTCT) (VPRT) (POT) Downgraded
-
Baird Downgrades QLogic (QLGC) to Neutral
-
Baird Downgrades Sequans Communications (SQNS) to Neutral
-
Baird Downgrades Constant Contact (CTCT) to Neutral
-
Baird Downgrades Varian Medical (VAR) to Neutral
-
Baird Downgrades NextEra Energy (NEE) to Neutral
-
Baird Upgrades Associated Estates Realty (AEC) to Outperform
-
Baird Upgrades Salient MLP and Energy (SMF) to Outperform
-
Analysts Bullish on Human Genome (HGSI) Shares as Investors Selling
-
Baird Reiterates an 'Outperform' on Human Genome Sciences (HGSI); Benlysta Off to a Solid Start, Q311 Estimates Look Safe
-
Baird Downgrades Swift Transportation (SWFT) to Neutral
-
Baird Starts Codexis, Inc. (CDXS) at Neutral
-
Baird Starts Gevo, Inc. (GEVO) at Outperform
-
Baird Starts Amyris, Inc. (AMRS) at Outperform
-
Baird Maintains a 'Neutral' on Alexion Pharmaceuticals (ALXN); Raising Estimates, Price Target; Dying for a Pull-Back
-
Notable Analyst Rating Changes 07/21: (WSM) (FE) (RHI) Upgraded; (ECL) (AMR) (INTC) Downgraded
-
Baird Upgrades Robert Half (RHI) to Outperform
-
Baird Reiterates an 'Outperform' on AMAG Pharmaceuticals (AMAG); Four Plus Two Equals Five? We Don't Think So - Staying with it Here
-
Notable Analyst Rating Changes 07/20: (MON) (WINN) (NWSA) Upgraded; (CSIQ) (HSOL) (BAC) Downgraded
-
Baird Upgrades Riverbed Technology (RVBD) to Outperform
-
Baird Upgrades Gen-Probe (GPRO) to Outperform
-
Baird Starts ClearBridge Energy (EMO) at Neutral
-
Baird Upgrades NuVasive (NUVA) to Outperform
-
ADS Tactical (ADSI) Sees IPO Price of $16 - $18/Share
-
Notable Analyst Rating Changes 07/18: (EQT) (ACI) (EOG) Upgraded; (NFLX) (LCC) (LNKD) Downgraded
-
Baird Starts NGL ENERGY (NGL) at Outperform
-
Baird Upgrades EQT Corp. (EQT) to Outperform
